Hematology/Oncology

Top Story

Immunotherapy 'tidal wave' demands interdisciplinary approach

Immunotherapy 'tidal wave' demands interdisciplinary approach
February 16, 2019
Meeting News

Retroperitoneal lymph node dissection demonstrates ‘excellent’ survival rates for testicular seminoma

February 16, 2019
SAN FRANCISCO — Retroperitoneal lymph node dissection conferred favorable survival rates among men with testicular seminoma used as first-line therapy or following…
Meeting News

Penile squamous cell carcinoma may benefit from therapies used in HPV-related cancers

February 15, 2019
SAN FRANCISCO — Characterization of genomic alterations in penile squamous cell carcinoma revealed involvement of multiple cancer genes that likely contribute to…
Meeting News

Sacituzumab govitecan response rates 'promising' in metastatic urothelial cancer

February 15, 2019
SAN FRANCISCO – Sacituzumab govitecan showed activity in patients with relapsed or refractory
Meeting NewsPerspective

Pembrolizumab shows promise for high-risk, BCG-unresponsive nonmuscle-invasive bladder cancer

February 15, 2019
SAN FRANCISCO — Pembrolizumab induced durable complete responses among patients with high-risk, nonmuscle-invasive, bacillus calmette-guérin-unresponsive bladder…
More Headlines »
CME ABIM MOC

Ace the Case: A 55-Year-Old Woman With an Oddly-Shaped, Raised Pigmented Lesion on Right Thigh

There is no commercial support for this activity.

This “Ace the Case” activity will utilize a case-based approach in a 55-year-old woman to discuss the diagnosis and…
More »
Video
Meeting News

VIDEO: Chromoendoscopy offers enhanced colonoscopy screening in IBD

February 8, 2019
More »
Resource Centers
ASH Annual Meeting and Exposition

ASH Annual Meeting and Exposition

CME ABIM MOC

Ace the Case: A 52-Year-Old Man with an Asymptomatic Neck Mass

There is no commercial support for this activity.

This educational activity will discuss the approach to diagnosis and management of a 52-year-old man who presents with…
More »
Current Issues
View the Current Issue
HemOnc Today Cell Therapy Next